 CELEBRATION, Fla., Jan. 13, 2021 GLOBE NEWSWIRE -- KemPharm, Inc. NASDAQ: KMPH, a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that the company is participating in BIO JPM and Fierce JPM Week 2021. Both events are being held virtually during the month of January alongside the J.P. Morgan 39th Annual Healthcare Conference 2021. 